Ledger.Open graph →
SEC Form D · filed January 22, 2021

Verve Therapeutics, Inc

Offering
$94.0M
Sold
$94.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Burt Adelman · Cambridge, MADirectorSekar Kathiresan · Cambridge, MAExec · DirectorAnthony Philippakis · Cambridge, MADirectorAndrew Bellinger · Cambridge, MAExecAndrew Ashe · Cambridge, MAExecJohn Evans · Grand Rapids, MIDirectorKrishna Yeshwant · New York, NYDirectorAndrew Ashe · Cambridge, MAExecBurt Adelman · Cambridge, MADirectorJohn Evans · Charlotte, VTDirectorSekar Kathiresan · Cambridge, MAExec · DirectorAnthony Philippakis · Cambridge, MADirectorKrishna Yeshwant · New York, NYDirectorAndrew Bellinger · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗